Coming soon

Events

See what BetaGlue will attend
San Francisco - JP Morgan Health Conference

44th Annual J.P. Morgan

Healthcare Conference

January 12-15, 2026 | San Francisco, California

Register interest: info@betaglue.com


Alexis
Peyroles
CEO
Salvatore
Calabrese
CFO
Gianluca
De Danieli
Head of Clinical Development
Spectrum Miami

Advancements in the fight against cancer

Spectrum Conference

January 15-17, 2026 | Miami (FL), USA

Register interest: info@betaglue.com


Alexis
Peyroles
CEO
Salvatore
Calabrese
CFO
Gianluca
De Danieli
Head of Clinical Development
MioLive - Roma

World Congress of Interventional Oncology

MIOLive

January 26-27, 2026 | Rome

Register interest: info@betaglue.com


Gianluca
De Danieli
Head of Clinical Development

What we’re building

News

Discover the latest from our lab and clinic
BetaGlue® renews the BoD: Dr Colin Story appointed CEO
Colin Story - BetaGlue

BetaGlue® renews the BoD: Dr Colin Story appointed CEO

The Board of Directors welcomes new Board Members Giovanni Cerutti and Luca Melindo who will support the company's future growth The Ordinary Shareholder’s Meeting of BetaGlue Technologies appointed the new…

Read more
1201 801 Betaglue® Therapeutics
BetaGlue® strengthens its expertise in strategic areas with four new managers

BetaGlue® strengthens its expertise in strategic areas with four new managers

Betty Polikar, Gianluca De Danieli, Pietro Bubba Bello and Gaia Bisaccioni strengthen the Clinical Research, Manufacturing and Quality areas

Read more
1200 801 Betaglue® Therapeutics
BetaGlue® published an article on the performance and safety of BAT-90 on ‘In Vivo’
In Vivo

BetaGlue® published an article on the performance and safety of BAT-90 on ‘In Vivo’

According to the article featured in the international peer-reviewed journal, BAT-90 could be considered a safe and innovative therapeutic option for unresectable solid liver tumors BetaGlue Technology’s Antonino Amato and…

Read more
1200 675 Betaglue® Therapeutics